【ChiCTR2000032575】Transpositioning of basilic vein for vascular acess for the hemodialysis: An experience of a tertiary care hospital
ChiCTR2000032575
结束
/
/
/
2020-05-03
/
/
慢性肾衰竭
Transpositioning of basilic vein for vascular acess for the hemodialysis: An experience of a tertiary care hospital
Transpositioning of basilic vein for vascular acess for the hemodialysis: An experience of a tertiary care hospital
to see the outcomes of BVT in chronic renal failure patients with thin veins in our population and compare our results with the international data
横断面
Ⅰ期
not randomization done
N/A
no funding source involved
/
160
/
2012-10-01
2018-12-28
/
all chronic renal failura patients undergoing basilic vein transpositioning for vascular access for hemodialysis；
请登录查看all renal failure patients with radiobasilic/ radiocephalic or ulnar fistulae and avf by grafts；
请登录查看no sponser
/
no sponser的其他临床试验
- short term outcomes for one stage and two stage basilic vein trans positioning (BVT) in patients with small cephalic vein caliber
- delayed presentation of acute limb ischemia: a sinister
- Transpositioning of basilic vein for vascular acess for the hemodialysis: An experience of a tertiary care hospital
- Association of Body Mass Index and diet with Symptomatic Gall Stone Disease: A Case-Control Study
巴基斯坦shifa college of medicine, Shifa Tameer-e-Millat university的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04